Author:
Jost S.,Rafflenbeul W.,Gulba D.,Hecker H.,Jost P.,Lichtlen P. R.
Publisher
Springer Berlin Heidelberg
Reference37 articles.
1. Kazda S, Garthoff N, Meyer H et al. (1980) Pharmacology of a new calcium antagonistic compound, isobutyl methyl l,4-dihydro-2, 6-dimethyl-4-(2-nitrophenyl)-3, 5-pyridine-dicarboxylate (nisoldipine, Bay K 5552). Drug Res 30 (II): 2144–2162
2. Serruys PW, Suryapranata H, Planellas J et al. (1985) Acute effects of intravenous nisoldipine on left ventricular function and coronary hemodynamics. Am J Cardiol 56: 140–146
3. Soward AL, De Feyter PJ, Hugenholtz PG et al. (1986) Coronary and systemic hemodynamic effects of intravenous nisoldipine. Am J Cardiol 58: 1199–1203
4. Godfraind T, Egleme C, Finet M et al. (1987) The actions of nifedipine and nisoldipine on the contractile activity of human coronary arteries and human cardiac tissue in vitro. Pharmacol Toxicol 61: 79–84
5. Kiowski W, Pfisterer M, Burkart F (1988) Vasodilating and myocardial effects of nisoldipine. In: Lichtlen PR. Hugenholtz PG (eds) Nisoldipine 1988. Schattauer, Stuttagart, pp 58–66